Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	93-94
Number of pages	2
Journal	Australian and New Zealand Journal of Psychiatry
Volume	51
Issue number	1
DOIs	https://doi.org/10.1177/0004867416667233
Publication status	Published - 1 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{a88a35af67ac4a508f8aedb8dfa3a912,

title = "Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration",

author = "Jayashri Kulkarni",

year = "2017",

month = jan,

day = "1",

doi = "10.1177/0004867416667233",

language = "English",

volume = "51",

pages = "93--94",

journal = "Australian and New Zealand Journal of Psychiatry",

issn = "0004-8674",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

AU - Kulkarni, Jayashri

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85008721492&partnerID=8YFLogxK

U2 - 10.1177/0004867416667233

DO - 10.1177/0004867416667233

M3 - Comment / Debate

AN - SCOPUS:85008721492

SN - 0004-8674

VL - 51

SP - 93

EP - 94

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

IS - 1

ER -